Skip to content
HowShorted

Cabaletta Bio, Inc. short interest in 2025

In 2025, Cabaletta Bio, Inc.'s disclosed short interest ran from 13.20% of shares outstanding on 15 Jan 2025 to 19.52% on 31 Dec 2025, a change of +6.32 percentage points. The year's high was 19.68% on 15 Dec 2025 and its low 6.09% on 15 Sep 2025, averaging 12.46% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.03 days on 31 Dec 2025. Full history: Cabaletta Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Cabaletta Bio, Inc. in 2025

2025 in figures

Start of year
13.20% (15 Jan 2025)
End of year
19.52% (31 Dec 2025)
Change
+6.32 pp
High
19.68% (15 Dec 2025)
Low
6.09% (15 Sep 2025)
Average
12.46%
Highest days to cover
11.03 (31 Dec 2025)
SEC filings marked
9

Every report in 2025

Cabaletta Bio, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202513.20%4.36results (8-K)
31 Jan 202512.79%5.16
14 Feb 202512.69%5.10
28 Feb 202513.83%4.17
14 Mar 202512.74%8.35
31 Mar 202512.08%6.7210-K filed, results (8-K)
15 Apr 202511.43%5.30
30 Apr 202512.02%10.79
15 May 202510.89%3.1210-Q filed, results (8-K)
30 May 202512.21%2.27
13 Jun 202512.74%1.84
30 Jun 202511.05%2.33
15 Jul 202512.88%3.93
31 Jul 202511.87%6.17
15 Aug 20256.90%3.9810-Q filed, results (8-K)
29 Aug 20256.37%5.65
15 Sep 20256.09%3.49
30 Sep 20256.61%2.08
15 Oct 202512.27%1.61
31 Oct 202513.45%2.38
14 Nov 202516.82%3.6310-Q filed, results (8-K)
28 Nov 202518.82%7.10
15 Dec 202519.68%9.06
31 Dec 202519.52%11.03

See also: Cabaletta Bio, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.